Company Quick10K Filing
Valmont Industries
10-Q 2021-03-27 Filed 2021-04-29
10-K 2020-12-26 Filed 2021-02-24
10-Q 2020-09-26 Filed 2020-10-28
10-Q 2020-06-27 Filed 2020-07-29
10-Q 2020-03-28 Filed 2020-04-29
10-K 2019-12-28 Filed 2020-02-26
10-Q 2019-09-28 Filed 2019-10-31
10-Q 2019-06-29 Filed 2019-07-31
10-Q 2019-03-30 Filed 2019-05-02
10-K 2018-12-29 Filed 2019-02-27
10-Q 2018-09-29 Filed 2018-11-01
10-Q 2018-06-30 Filed 2018-08-01
10-Q 2018-03-31 Filed 2018-04-27
10-K 2017-12-30 Filed 2018-02-28
10-Q 2017-09-30 Filed 2017-11-02
10-Q 2017-07-01 Filed 2017-07-27
10-Q 2017-04-01 Filed 2017-04-28
10-K 2016-12-31 Filed 2017-03-01
10-Q 2016-09-24 Filed 2016-10-27
10-Q 2016-06-25 Filed 2016-07-28
10-Q 2016-03-26 Filed 2016-04-28
10-K 2015-12-26 Filed 2016-02-24
10-Q 2015-09-26 Filed 2015-10-30
10-Q 2015-06-27 Filed 2015-07-29
10-Q 2015-03-28 Filed 2015-04-30
10-K 2014-12-27 Filed 2015-02-25
10-Q 2014-09-27 Filed 2014-10-30
10-Q 2014-06-28 Filed 2014-07-30
10-Q 2014-03-29 Filed 2014-04-30
10-K 2013-12-28 Filed 2014-02-25
10-Q 2013-09-28 Filed 2013-10-24
10-Q 2013-06-29 Filed 2013-07-25
10-Q 2013-03-30 Filed 2013-05-02
10-K 2012-12-29 Filed 2013-02-26
10-Q 2012-09-29 Filed 2012-10-29
10-Q 2012-06-30 Filed 2012-07-27
10-Q 2012-03-31 Filed 2012-04-30
10-K 2011-12-31 Filed 2012-02-28
10-Q 2011-09-24 Filed 2011-10-27
10-Q 2011-06-25 Filed 2011-07-29
10-Q 2011-03-26 Filed 2011-04-29
10-K 2010-12-25 Filed 2011-02-23
10-Q 2010-09-25 Filed 2010-10-29
10-Q 2010-06-26 Filed 2010-08-03
10-Q 2010-03-27 Filed 2010-04-29
10-K 2009-12-26 Filed 2010-02-23
8-K 2020-10-21
8-K 2020-09-18
8-K 2020-07-22
8-K 2020-06-09
8-K 2020-04-22
8-K 2020-03-30
8-K 2020-03-26
8-K 2020-02-21
8-K 2020-02-19
8-K 2019-10-28
8-K 2019-10-23
8-K 2019-09-19
8-K 2019-07-13
8-K 2019-06-29
8-K 2019-06-11
8-K 2019-04-23
8-K 2019-02-20
8-K 2018-12-31
8-K 2018-11-06
8-K 2018-10-31
8-K 2018-10-23
8-K 2018-09-20
8-K 2018-09-19
8-K 2018-07-23
8-K 2018-07-12
8-K 2018-06-19
8-K 2018-06-08
8-K 2018-04-18
8-K 2018-03-12
8-K 2018-03-06
8-K 2018-02-21
8-K 2018-01-09

Valmont Industries Financials

VMI Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin

Comps ($MM TTM) Market Cap Gross Margin EV/EBITDA Ret on Assets Assets Liabilities Revenue G Profit Net Income EBITDA EV
024 Pharma (EEIG)
Bioquest Corp (BQST)
11 Good Energy (ELVN)
BriaCell Therapeutics Corp. (BCTXW)
1347 Capital Corp (TFSC)
DD3 Acquisition Corp. II (DDMXW)
8i Acquisition 2 Corp. (LAX)
Acumen Pharmaceuticals, Inc. (ABOS)
Aerovate Therapeutics, Inc. (AVTE)
Ameren Illinois Co (AILNP)
Frontier Investment Corp (FICV)
Gobi Acquisition Corp. (GOBI)
HEALTH REVENUE ASSURANCE HOLDINGS, INC. (HRAA)
Ocean Biomedical, Inc. (OCEA)
SERA PROGNOSTICS, INC. (SERA)
Xiaoju Kuaizhi Inc. (DIDI)
1PM Industries (OPMZ)
1st Century Bancshares (FCTY)
COMSovereign Holding Corp. (COMSW)
ALABAMA POWER CO (APRCP)

Balance Sheet ($MM)2010-06-262010-09-252010-12-252011-03-262011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash314323347358327337363340328427414420490543614488456452372318318313349388344349400425448493493480723296313211257327
Accounts Receivable
Inventory297296280324366378394441441433412451413427380425382385360380380368341351372380350389383403421370382400384396407377
PP&E8228588658879078909129459429659951,0251,0191,0451,0171,1721,1601,1381,1401,1241,1241,0831,0811,1011,1061,1201,1061,1301,1481,1701,1661,1371,1321,1541,1611,1971,2261,234
Assets2,0302,0592,0912,1802,2232,2092,3062,3832,3972,4942,5692,6172,6522,7492,7762,8862,8592,8632,7302,5842,5672,4902,3992,5532,5482,5412,5432,7752,5562,6182,6022,6182,7792,5632,5302,6462,7122,725
Accounts Payable203179180207224222235236222218212212212214216234209210197189186187180183183171177195193216228191194200218219228198
Long-Term Debt518483469485489495475601588473473602533540471535545769768767766766765758757756756755755755755755989737743742766765
Liabilities1,2451,2151,1751,2241,2021,1986856957368889119361,0161,0791,2281,1621,1171,1306815695264854994874704464684734915125795681,6671,5061,4711,5681,6301,639
Stockholders' Equity7858449169561,0221,0111,6221,6881,6601,6061,6571,6821,6351,6701,5491,7241,7421,7332,0482,0152,0422,0051,9002,0672,0782,0952,0752,3022,0652,1062,0232,0501,1121,0571,0601,0781,0821,087
Income Statement ($MM)2010-06-262010-09-252010-12-252011-03-262011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Revenue482528599568695702777754857759851875927778828752843766763670682633634597640610675637713681715699682679697692701690
Cost of Revenue353395441431501505558531568537591584617552-6475456225661,4895055134765054364654554847352951751529507514548527520514
Gross Profit129133158136168167-137186199192224235261226223207220200525165170157129161175155165165183164170169175164150165180176
R&D
SG&A9185959199951181031021021131171171165210811611229910811610512099103102109100105104107105111110110117112
Tax121420131428202852343035754618306417631714125161914-815211456132014122215
Net Income192835274844295361582527891595257663742322914-2934433071404737-240357374242
Cash Flow ($MM)2010-06-262010-09-252010-12-252011-03-262011-06-252011-09-242011-12-312012-03-312012-06-302012-09-292012-12-292013-03-302013-06-292013-09-282013-12-282014-03-292014-06-282014-09-272014-12-272015-03-282015-06-272015-09-262015-12-262016-03-262016-06-252016-09-242016-12-312017-04-012017-07-012017-09-302017-12-302018-03-312018-06-302018-09-292018-12-312019-03-302019-06-292019-09-28
Cash Operating3167614119453142791001116426-680915663648981-14792363266113321148106126
Cash Investing-1-4-12-51-1664646-27-11056-24-406124-169-610-4-7-2313-10-15-1211-7-19-8347-137-79-36-24
Cash Financing-34-418-3300-310-22-2-4-318719-38-73-0-64-43-301-29-30-132-11-8-103194-302-32-24-27